Ocular Surface Disease

Botulinum toxin shows promise in treating eyelid-related ocular surface disease

Botulinum toxin is emerging as a useful treatment option for eyelid-related ocular surface disease (EAOSD) by improving eyelid mechanics, reducing abnormal blinking, and decreasing friction or exposure of the ocular surface, according to a recent report. Botulinum toxin temporarily weakens targeted muscles by blocking acetylcholine at neuromuscular junctions. When precisely...